resveratrol has been researched along with ryanodine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, E; Campos-Toimil, M; Elíes, J; Orallo, F; Verde, I | 1 |
| Chen, J; Chen, L; Cheng, R; Ma, Q; Pan, X; Wang, G; Wang, L; Wang, W; Wu, H; Zhang, J; Zhang, M | 1 |
2 other study(ies) available for resveratrol and ryanodine
| Article | Year |
|---|---|
Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine Vasopressin; Blood Vessels; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Line; Fluorescent Dyes; Fura-2; Membrane Potentials; Myocytes, Smooth Muscle; Patch-Clamp Techniques; Rats; Resveratrol; Ryanodine; Stereoisomerism; Stilbenes | 2007 |
Resveratrol-induced antinociception is involved in calcium channels and calcium/caffeine-sensitive pools.
Topics: Analgesics; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Chelating Agents; Calcium Chloride; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Egtazic Acid; Male; Mice, Inbred ICR; Nociception; Nociceptive Pain; Phosphorylation; Reaction Time; Resveratrol; Ryanodine; Spinal Cord; Stilbenes; Time Factors | 2017 |